In a Dutch family with autosomal recessive hearing loss, genome-wide single-nucleotide polymorphism analysis mapped the genetic defect to the DFNB7/11 locus. A novel homozygous A-to-G change in the TMC1 gene was detected near the splice donor site of intron 19 (c.1763+3A→G) segregating with the hearing loss in this family. One of the 6 transmembrane domains and the actual TMC channel domain are predicted to be absent in the mutant protein. The sensorineural hearing impairment in this DFNB7/11 family has a postlingual onset. Audiometric analysis initially showed a steeply downward-sloping threshold configuration. The progressive phenotype in this family resembles the phenotype previously described for families with dominant TMC1 mutations (DFNA36) rather than that of families with recessive TMC1 mutations (DFNB7/11) which invariably cause severe-to-profound prelingual hearing impairment.

Keywords:
Cochlear implant, Sensorineural hearing loss, progressive, Audioprofile, DFNB7/11, TMC1
1.
Ahmed ZM, Masmoudi S, Kalay E, et al: Mutations of LRTOMT, a fusion gene with alternative reading frames, cause nonsyndromic deafness in humans. Nat Genet 2008;40:1335–1340.
2.
Bock GR, Steel KP: Inner ear pathology in the deafness mutant mouse. Acta Otolaryngol 1983;96:39–47.
3.
Bom SJH, de Leenheer EMR, Lemaire FX, et al: Speech recognition scores related to age and degree of hearing impairment in DFNA2/KCNQ4 and DFNA9/COCH. Arch Otolaryngol Head Neck Surg 2001;127:1045–1048.
4.
Collin RW, de Heer AM, Oostrik J, et al: Mid-frequency DFNA8/12 hearing loss caused by a synonymous TECTA mutation that affects an exonic splice enhancer. Eur J Hum Genet 2008a;16:1430–1436.
5.
Collin RW, Kalay E, Tariq M, et al: Mutations of ESRRB encoding estrogen-related receptor-beta cause autosomal-recessive nonsyndromic hearing impairment DFNB35. Am J Hum Genet 2008b;82:125–138.
6.
Cremers CW: Autosomal recessive non-syndromal progressive sensorineural deafness in childhood: a separate clinical and genetic entity. Int J Pediatr Otorhinolaryngol 1979;1:193–199.
7.
de Leenheer EMR, Huygen PLM, Coucke PJ, et al: Longitudinal and cross-sectional phenotype analysis in a new, large Dutch DFNA2/KCNQ4 family. Ann Otol Rhinol Laryngol 2002;111:267–274.
8.
Deol MS, Kocher WA: A new gene for deafness in the mouse. Heredity 1958;12:463–466.
9.
Felder E, Schrott-Fischer A: Quantitative evaluation of myelinated nerve fibres and hair cells in cochleae of humans with age-related high-tone hearing loss. Hear Res 1995;91:19–32.
10.
Gamundi MJ, Hernan I, Muntanyola M, et al: Transcriptional expression of cis- acting and trans- acting splicing mutations cause autosomal dominant retinitis pigmentosa. Hum Mutat 2008;29:869–878.
11.
Grillet N, Schwander M, Hildebrand MS, et al: Mutations in LOXHD1, an evolutionarily conserved stereociliary protein, disrupt hair cell function in mice and cause progressive hearing loss in humans. Am J Hum Genet 2009;85:328–337.
12.
Hilgert N, Alasti F, Dieltjens N, et al: Mutation analysis of TMC1 identifies four new mutations and suggests an additional deafness gene at loci DFNA36 and DFNB7/11. Clin Genet 2008;74:223–232.
13.
Hilgert N, Monahan K, Kurima K, et al: Amino acid 572 in TMC1: hot spot or critical functional residue for dominant mutations causing hearing impairment. J Hum Genet 2009;54:188–190.
14.
Huygen PLM, Pennings RJE, Cremers CWRJ: Characterizing and distinguishing progressive phenotypes in nonsyndromic autosomal dominant hearing impairment. Audiol Med 2003;1:37–46.
15.
International Organization for Standardization: ISO 7029. Geneva, ISO, 1984.
16.
International Organization for Standardization: ISO 389. Geneva, ISO, 1985.
17.
International Organization for Standardization: ISO 8253-1. Geneva, ISO, 1989.
18.
Janecke AR, Hirst-Stadlmann A, Günther B, et al: Progressive hearing loss, and recurrent sudden sensorineural hearing loss associated with GJB2 mutations: phenotypic spectrum and frequencies of GJB2 mutations in Austria. Hum Genet 2002;11:145–153.
19.
Kalay E, Karaguzel A, Caylan R, et al: Four novel TMC1 (DFNB7/DFNB11) mutations in Turkish patients with congenital autosomal recessive nonsyndromic hearing loss. Hum Mutat 2005;26:591.
20.
Keresztes G, Mutai H, Heller S: TMC and EVER genes belong to a larger novel family, the TMC gene family encoding transmembrane proteins. BMC Genomics 2003;4:24.
21.
Kitajiri S, Makishima T, Friedman TB, et al: A novel mutation at the DFNA36 hearing loss locus reveals a critical function and potential genotype-phenotype correlation for amino acid 572 of TMC1. Clin Genet 2007a;71:148–152.
22.
Kitajiri SI, McNamara R, Makishima T, et al: Identities, frequencies and origins of TMC1 mutations causing DFNB7/B11 deafness in Pakistan. Clin Genet 2007b;72:546–550.
23.
Kurima K, Peters LM, Yang Y, et al: Dominant and recessive deafness caused by mutations of a novel gene, TMC1, required for cochlear hair cell function. Nat Genet 2002;30:277–284.
24.
Kurima K, Yang Y, Sorber K, et al: Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis. Genomics 2003;82:300–308.
25.
Makishima T, Kurima K, Brewer CC, et al: Early onset and rapid progression of dominant nonsyndromic DFNA36 hearing loss. Otol Neurotol 2004;25:714–719.
26.
Marcotti W, Erven A, Johnson SL, et al: Tmc1 is necessary for normal functional maturation and survival of inner and outer hair cells in the mouse cochlea. J Physiol 2006;574:677–698.
27.
Marres HAM, van Ewijk M, Huygen PLM, et al: Inherited nonsyndromic hearing loss: an audiovestibular study in a large family with autosomal dominant progressive hearing loss related to DFNA2. Arch Otolaryngol Head Neck Surg 1997;123:573–577.
28.
Mazzoli M, van Camp G, Newton V, et al: Recommendations for the description of genetic and audiological data for families with nonsyndromic hereditary hearing impairment. Audiol Med 2003;1:148–150.
29.
McKusick VA: Mendelian Inheritance in Man. Catalogs of Autosomal Dominant, Autosomal Recessive, and X-Linked Phenotypes, ed 10. Baltimore, Johns Hopkins University Press, 1992.
30.
Meyer CG, Gasmelseed NM, Mergani A, et al: Novel TMC1 structural and splice variants associated with congenital nonsyndromic deafness in a Sudanese pedigree. Hum Mutat 2005;25:100.
31.
Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
32.
Morton NE: Genetic epidemiology of hearing impairment. Ann NY Acad Sci 1991;630:16–31.
33.
Mustapha M, Chardenoux S, Nieder A, et al: A sensorineural progressive autosomal recessive form of isolated deafness, DFNB13, maps to chromosome 7q34–q36. Eur J Hum Genet 1998;6:245–250.
34.
Nannya Y, Sanada M, Nakazaki K, et al: A robust algorithm for copy number detection using high-density oligonucleotide single-nucleotide polymorphism genotyping arrays. Cancer Res 2005;65:6071–6079.
35.
Nelson EG, Hinojosa R: Presbycusis: a human temporal bone study of individuals with downward-sloping audiometric patterns of hearing loss and review of the literature. Laryngoscope 2006;116:1–12.
36.
Noben-Trauth K, Zheng QY, Johnson KR: Association of cadherin 23 with polygenic inheritance and genetic modification of sensorineural hearing loss. Nat Genet 2003;35:21–23.
37.
Noguchi Y, Kurima K, Makishima T, et al: Multiple quantitative trait loci modify cochlear hair cell degeneration in the Beethoven (Tmc1Bth) mouse model of progressive hearing loss DFNA36. Genetics 2006;173:2111–2119.
38.
Santos RLP, Aulchenko YS, Huygen PLM, et al: Hearing impairment in Dutch patients with connexin 26 (GJB2) and connexin 30 (GJB6) mutations. Int J Pediatr Otorhinolaryngol 2005a;69:165–174.
39.
Santos RL, Wajid M, Khan MN, et al: Novel sequence variants in the TMC1 gene in Pakistani families with autosomal recessive hearing impairment. Hum Mutat 2005b;26:396.
40.
Schwander M, Sczaniecka A, Grillet N, et al: A forward genetics screen in mice identifies recessive deafness traits and reveals that pejvakin is essential for outer hair cell function. J Neurosci 2007;27:2163–2175.
41.
Sirmaci A, Duman D, Öztürkmen-Akay H, et al: Mutations in TMC1 contribute significantly to nonsyndromic autosomal recessive sensorineural hearing loss: a report of five novel mutations. Int J Pediatr Otorhinolaryngol 2009;73:699–705.
42.
Steel KP, Bock GR: The nature of inherited deafness in deafness mice. Nature 1980;288:159–161.
43.
Tlili A, Rebeh IB, Aifa-Hmani M, et al: TMC1 but not TMC2 is responsible for autosomal recessive nonsyndromic hearing impairment in Tunisian families. Audiol Neurootol 2008;13:213–218.
44.
Toriello HV, Reardon W, Gorlin RJ: Hereditary Hearing Loss and Its Syndromes. Oxford Monographs on Medical Genetics 50. Oxford, Oxford University Press, 2004.
45.
van Camp G, Smith RJH: Hereditary hearing loss homepage. 2008. http://webh01.ua.ac.be/hhh/.
46.
Verhaegen VJ, Mylanus EA, Cremers CW, et al: Audiological application criteria for implantable hearing aid devices: a clinical experience at the Nijmegen ORL clinic. Laryngoscope 2008;118:1645–1649.
47.
Verhagen WIM, ter Bruggen JP, Huygen PLM: Oculomotor, auditory, and vestibular responses in myotonic dystrophy. Arch Neurol 1992;49:954–960.
48.
Veske A, Oehlmann R, Younus F, et al: Autosomal recessive non-syndromic deafness locus (DFNB8) maps on chromosome 21q22 in a large consanguineous kindred from Pakistan. Hum Mol Genet 1996;5:165–168.
49.
Vreugde S, Erven A, Kros CJ, et al: Beethoven, a mouse model for dominant, progressive hearing loss DFNA36. Nat Genet 2002;30:257–258.
50.
Walsh T, Walsh V, Vreugde S, et al: From flies’ eyes to our ears: mutations in a human class III myosin cause progressive nonsyndromic hearing loss DFNB30. Proc Natl Acad Sci USA 2002;99:7518–7523.
51.
Yang T, Carmi R, Bayazit Y, et al: Mutation screening of TMC1 in DFNB7/11 families. Am J Hum Genet 2002;71(suppl 4):319.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.